Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

To deliver the first medical treatment dedicated to patients with haemorrhagic stroke

Project description

Nanoparticle-based delivery of thrombolytic drugs to the brain

The rupture of a blood vessel in the brain can lead to localised bleeding (haematoma), clot formation and haemorrhagic stroke. Fast resolution or removal of the haematoma is paramount for reducing mortality in patients with haemorrhagic stroke. Funded by the European Innovation Council, the OP2DRAIN project introduces a novel nanotechnology-based system for delivering drugs directly into the brain. The first drug to be tested is an optimised thrombolytic agent with an improved safety profile that avoids neurotoxicity. The OP2DRAIN nanoparticles protect the drugs to be delivered, ensuring specific targeting and slow release.

Objective

The NANOp2lysis platform is a deep-tech technology to protect active enzymes by a reversible precipitation and to produce solid-state nanoparticles. Such particles can then be loaded at high concentration into tailored carrier (with specific targeting / slow delivery characteristics).
O2L-001 (derived from NANOp2Lysis) is the first effective and safe treatment to remove intracerebral hematoma and reduce disability and death following acute hemorrhagic stroke (AHS). It has been tailored to be locally injected, after micro-invasive surgery, via a catheter at the core of the hematoma. The in vivo gelation of the product at body temperature allows a local and slow delivery of our new thrombolytic agent, OptPA. The main characteristics of O2L-001 are thus the following:
- EASY. simplified model of administration (unique injection)
- EFFICIENT. better thrombolytic effect on best translational model (vs gold standard)
- SAFE. reduced side effect (bleeding and neurotoxoxicity vs gold standard)

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2021-ACCELERATOROPEN-01

See all projects funded under this call

Coordinator

Op2Lysis
Net EU contribution
€ 2 500 000,00
Address
117 avenue Victor Hugo
92100 Boulogne-Billancourt
France
SME
Yes
Region
Ile-de-France Ile-de-France Hauts-de-Seine
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 10 535 727,00

Participants (1)